These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29534847)

  • 1. Neuregulin1 modulation of experimental autoimmune encephalomyelitis (EAE).
    Allender E; Deol H; Schram S; Maheras KJ; Gow A; Simpson EH; Song F
    J Neuroimmunol; 2018 May; 318():56-64. PubMed ID: 29534847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complexity of trophic factor signaling in experimental autoimmune encephalomyelitis: differential expression of neurotrophic and gliotrophic factors.
    Song F; Bandara M; Deol H; Loeb JA; Benjamins J; Lisak RP
    J Neuroimmunol; 2013 Sep; 262(1-2):11-8. PubMed ID: 23763772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses.
    Lee CH; Jeon SJ; Cho KS; Moon E; Sapkota A; Jun HS; Ryu JH; Choi JW
    Mol Neurobiol; 2018 Apr; 55(4):3007-3020. PubMed ID: 28456941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myelin oligodendrocyte glycoprotein (MOG35-55)-induced experimental autoimmune encephalomyelitis is ameliorated in interleukin-32 alpha transgenic mice.
    Yun J; Gu SM; Yun HM; Son DJ; Park MH; Lee MS; Hong JT
    Oncotarget; 2015 Dec; 6(38):40452-63. PubMed ID: 26564962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
    Ingwersen J; Wingerath B; Graf J; Lepka K; Hofrichter M; Schröter F; Wedekind F; Bauer A; Schrader J; Hartung HP; Prozorovski T; Aktas O
    J Neuroinflammation; 2016 Feb; 13():48. PubMed ID: 26920550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE.
    Eltayeb S; Berg AL; Lassmann H; Wallström E; Nilsson M; Olsson T; Ericsson-Dahlstrand A; Sunnemark D
    J Neuroinflammation; 2007 May; 4():14. PubMed ID: 17484785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p38 MAP Kinase Signaling in Microglia Plays a Sex-Specific Protective Role in CNS Autoimmunity and Regulates Microglial Transcriptional States.
    McGill MM; Richman AR; Boyd JR; Sabikunnahar B; Lahue KG; Montgomery TL; Caldwell S; Varnum S; Frietze S; Krementsov DN
    Front Immunol; 2021; 12():715311. PubMed ID: 34707603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atf6α deficiency suppresses microglial activation and ameliorates pathology of experimental autoimmune encephalomyelitis.
    Ta HM; Le TM; Ishii H; Takarada-Iemata M; Hattori T; Hashida K; Yamamoto Y; Mori K; Takahashi R; Kitao Y; Hori O
    J Neurochem; 2016 Dec; 139(6):1124-1137. PubMed ID: 27333444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of microglial/macrophage activation by macrophage inhibitory factor (TKP) or tuftsin (TKPR) attenuates the disease course of experimental autoimmune encephalomyelitis.
    Bhasin M; Wu M; Tsirka SE
    BMC Immunol; 2007 Jul; 8():10. PubMed ID: 17634104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Slowing disease progression in the SOD1 mouse model of ALS by blocking neuregulin-induced microglial activation.
    Liu J; Allender E; Wang J; Simpson EH; Loeb JA; Song F
    Neurobiol Dis; 2018 Mar; 111():118-126. PubMed ID: 29278738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of colony-stimulating factor-1 in mouse spinal cord with experimental autoimmune encephalomyelitis correlates with microglial activation and neuronal loss.
    Gushchina S; Pryce G; Yip PK; Wu D; Pallier P; Giovannoni G; Baker D; Bo X
    Glia; 2018 Oct; 66(10):2108-2125. PubMed ID: 30144320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis.
    Berard JL; Zarruk JG; Arbour N; Prat A; Yong VW; Jacques FH; Akira S; David S
    Glia; 2012 Jul; 60(7):1145-59. PubMed ID: 22499213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IKKβ-mediated inflammatory myeloid cell activation exacerbates experimental autoimmune encephalomyelitis by potentiating Th1/Th17 cell activation and compromising blood brain barrier.
    Lee MJ; Bing SJ; Choi J; Jang M; Lee G; Lee H; Chang BS; Jee Y; Lee SJ; Cho IH
    Mol Neurodegener; 2016 Jul; 11(1):54. PubMed ID: 27450563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCR3 signaling in glial cells ameliorates experimental autoimmune encephalomyelitis by restraining the generation of a pro-Th17 cytokine milieu and reducing CNS-infiltrating Th17 cells.
    Chung CY; Liao F
    J Neuroinflammation; 2016 Apr; 13(1):76. PubMed ID: 27068264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of system x
    Merckx E; Albertini G; Paterka M; Jensen C; Albrecht P; Dietrich M; Van Liefferinge J; Bentea E; Verbruggen L; Demuyser T; Deneyer L; Lewerenz J; van Loo G; De Keyser J; Sato H; Maher P; Methner A; Massie A
    J Neuroinflammation; 2017 Jan; 14(1):9. PubMed ID: 28086920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
    Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S
    PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurodegeneration and inflammation in hippocampus in experimental autoimmune encephalomyelitis induced in rats by one--time administration of encephalitogenic T cells.
    Kurkowska-Jastrzębska I; Swiątkiewicz M; Zaremba M; Cudna A; Piechal A; Pyrzanowska J; Widy-Tyszkiewicz E; Członkowska A
    Neuroscience; 2013 Sep; 248():690-8. PubMed ID: 23806721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RGS10 deficiency ameliorates the severity of disease in experimental autoimmune encephalomyelitis.
    Lee JK; Kannarkat GT; Chung J; Joon Lee H; Graham KL; Tansey MG
    J Neuroinflammation; 2016 Feb; 13():24. PubMed ID: 26831924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of Nrf2 exacerbates the visual deficits and optic neuritis elicited by experimental autoimmune encephalomyelitis.
    Larabee CM; Desai S; Agasing A; Georgescu C; Wren JD; Axtell RC; Plafker SM
    Mol Vis; 2016; 22():1503-1513. PubMed ID: 28050123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microglial and astroglial reactions to inflammatory lesions of experimental autoimmune encephalomyelitis in the rat central nervous system.
    Matsumoto Y; Ohmori K; Fujiwara M
    J Neuroimmunol; 1992 Mar; 37(1-2):23-33. PubMed ID: 1372328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.